About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Global Veterinary Dermatology Drugs Market Size, CAGR of 9.5%, Forecast by 2031
Veterinary Dermatology Drugs Market

Veterinary Dermatology Drugs Market Size, Share & Trends Analysis Report By Drug (Non-steroidal anti-inflammatory drugs (NSAIDS), Antibiotics, Veterinary antifungal drug), By Animal Type (Large animals, Small animals), By End Users (Veterinary Hospitals, Veterinary Clinics) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRHI433DR
Author : Straits Research
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Veterinary Dermatology Drugs Market Introduction
    2. By Drug
      1. Introduction
        1. Drug By Value
      2. Non-steroidal anti-inflammatory drugs (NSAIDS)
        1. By Value
      3. Antibiotics
        1. By Value
      4. Veterinary antifungal drug
        1. By Value
    3. By Animal Type
      1. Introduction
        1. Animal Type By Value
      2. Large animals
        1. By Value
      3. Small animals
        1. By Value
    4. By End Users
      1. Introduction
        1. End Users By Value
      2. Veterinary Hospitals
        1. By Value
      3. Veterinary Clinics
        1. By Value
    1. Introduction
    2. By Drug
      1. Introduction
        1. Drug By Value
      2. Non-steroidal anti-inflammatory drugs (NSAIDS)
        1. By Value
      3. Antibiotics
        1. By Value
      4. Veterinary antifungal drug
        1. By Value
    3. By Animal Type
      1. Introduction
        1. Animal Type By Value
      2. Large animals
        1. By Value
      3. Small animals
        1. By Value
    4. By End Users
      1. Introduction
        1. End Users By Value
      2. Veterinary Hospitals
        1. By Value
      3. Veterinary Clinics
        1. By Value
    5. U.S.
      1. By Drug
        1. Introduction
          1. Drug By Value
        2. Non-steroidal anti-inflammatory drugs (NSAIDS)
          1. By Value
        3. Antibiotics
          1. By Value
        4. Veterinary antifungal drug
          1. By Value
      2. By Animal Type
        1. Introduction
          1. Animal Type By Value
        2. Large animals
          1. By Value
        3. Small animals
          1. By Value
      3. By End Users
        1. Introduction
          1. End Users By Value
        2. Veterinary Hospitals
          1. By Value
        3. Veterinary Clinics
          1. By Value
    6. Canada
    1. Introduction
    2. By Drug
      1. Introduction
        1. Drug By Value
      2. Non-steroidal anti-inflammatory drugs (NSAIDS)
        1. By Value
      3. Antibiotics
        1. By Value
      4. Veterinary antifungal drug
        1. By Value
    3. By Animal Type
      1. Introduction
        1. Animal Type By Value
      2. Large animals
        1. By Value
      3. Small animals
        1. By Value
    4. By End Users
      1. Introduction
        1. End Users By Value
      2. Veterinary Hospitals
        1. By Value
      3. Veterinary Clinics
        1. By Value
    5. U.K.
      1. By Drug
        1. Introduction
          1. Drug By Value
        2. Non-steroidal anti-inflammatory drugs (NSAIDS)
          1. By Value
        3. Antibiotics
          1. By Value
        4. Veterinary antifungal drug
          1. By Value
      2. By Animal Type
        1. Introduction
          1. Animal Type By Value
        2. Large animals
          1. By Value
        3. Small animals
          1. By Value
      3. By End Users
        1. Introduction
          1. End Users By Value
        2. Veterinary Hospitals
          1. By Value
        3. Veterinary Clinics
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest of Europe
    1. Introduction
    2. By Drug
      1. Introduction
        1. Drug By Value
      2. Non-steroidal anti-inflammatory drugs (NSAIDS)
        1. By Value
      3. Antibiotics
        1. By Value
      4. Veterinary antifungal drug
        1. By Value
    3. By Animal Type
      1. Introduction
        1. Animal Type By Value
      2. Large animals
        1. By Value
      3. Small animals
        1. By Value
    4. By End Users
      1. Introduction
        1. End Users By Value
      2. Veterinary Hospitals
        1. By Value
      3. Veterinary Clinics
        1. By Value
    5. China
      1. By Drug
        1. Introduction
          1. Drug By Value
        2. Non-steroidal anti-inflammatory drugs (NSAIDS)
          1. By Value
        3. Antibiotics
          1. By Value
        4. Veterinary antifungal drug
          1. By Value
      2. By Animal Type
        1. Introduction
          1. Animal Type By Value
        2. Large animals
          1. By Value
        3. Small animals
          1. By Value
      3. By End Users
        1. Introduction
          1. End Users By Value
        2. Veterinary Hospitals
          1. By Value
        3. Veterinary Clinics
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Taiwan
    11. South East Asia
    12. Rest of Asia-Pacific
    1. Introduction
    2. By Drug
      1. Introduction
        1. Drug By Value
      2. Non-steroidal anti-inflammatory drugs (NSAIDS)
        1. By Value
      3. Antibiotics
        1. By Value
      4. Veterinary antifungal drug
        1. By Value
    3. By Animal Type
      1. Introduction
        1. Animal Type By Value
      2. Large animals
        1. By Value
      3. Small animals
        1. By Value
    4. By End Users
      1. Introduction
        1. End Users By Value
      2. Veterinary Hospitals
        1. By Value
      3. Veterinary Clinics
        1. By Value
    5. UAE
      1. By Drug
        1. Introduction
          1. Drug By Value
        2. Non-steroidal anti-inflammatory drugs (NSAIDS)
          1. By Value
        3. Antibiotics
          1. By Value
        4. Veterinary antifungal drug
          1. By Value
      2. By Animal Type
        1. Introduction
          1. Animal Type By Value
        2. Large animals
          1. By Value
        3. Small animals
          1. By Value
      3. By End Users
        1. Introduction
          1. End Users By Value
        2. Veterinary Hospitals
          1. By Value
        3. Veterinary Clinics
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest of MEA
    1. Introduction
    2. By Drug
      1. Introduction
        1. Drug By Value
      2. Non-steroidal anti-inflammatory drugs (NSAIDS)
        1. By Value
      3. Antibiotics
        1. By Value
      4. Veterinary antifungal drug
        1. By Value
    3. By Animal Type
      1. Introduction
        1. Animal Type By Value
      2. Large animals
        1. By Value
      3. Small animals
        1. By Value
    4. By End Users
      1. Introduction
        1. End Users By Value
      2. Veterinary Hospitals
        1. By Value
      3. Veterinary Clinics
        1. By Value
    5. Brazil
      1. By Drug
        1. Introduction
          1. Drug By Value
        2. Non-steroidal anti-inflammatory drugs (NSAIDS)
          1. By Value
        3. Antibiotics
          1. By Value
        4. Veterinary antifungal drug
          1. By Value
      2. By Animal Type
        1. Introduction
          1. Animal Type By Value
        2. Large animals
          1. By Value
        3. Small animals
          1. By Value
      3. By End Users
        1. Introduction
          1. End Users By Value
        2. Veterinary Hospitals
          1. By Value
        3. Veterinary Clinics
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest of LATAM
    1. Veterinary Dermatology Drugs Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Bayer HealthCare Animal Health Inc. (U.S.)
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Boehringer Ingelheim Vetmedica, Inc.(U.S.)
    3. Ceva(France)
    4. Zoetis Inc.(U.S.)
    5. Elanco(U.S.)
    6. IDEXX Laboratories(U.S.)
    7. Boehringer Ingelheim International GmbH. (France)
    8. Vetoquinol S.A.(France)
    9. Virbac(France).
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
The global veterinary pharmaceutical drugs market size was valued at USD 50.93 billion in 2023. It is estimated to reach USD 97.64 billion by 2032, growing at a CAGR of 7.5% during the forecast period (2024–2032). The global veterinary pha
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.